EU Signs Off on Omnibus VI, Easing Cosmetics and Chemical Rules

The Council of the European Union has given final approval to the Omnibus VI regulation, amending the EU Cosmetics Regulation, the Classification, Labelling and Packaging (CLP) Regulation and fertilising-product legislation in a single package. The measure cuts administrative burdens for cosmetics manufacturers and ingredient suppliers while leaving existing safety and environmental protections intact.
The Council signed off on 19 November 2026, according to its press release. The regulation now heads to the EU's Official Journal, where it's expected to appear before the end of 2026. It enters force 20 days after publication.
What changes for cosmetics formulators?
The most concrete change touches carcinogenic, mutagenic and reprotoxic (CMR) substances. The legislation introduces more flexible transition periods for phasing out certain CMR materials, giving manufacturers additional time to identify safer alternatives. That extra runway matters for formulation teams, since substitution work — reformulation, stability testing, compatibility checks — typically runs on multi-year cycles.
Nanomaterials get a different outcome. Existing notification requirements for nanomaterials in cosmetics remain in place, so brands using nano-sized UV filters or colorants keep their current reporting obligations to the EU portal.
The package also simplifies reporting obligations more broadly, cuts duplicated requirements across the three regimes and streamlines regulatory procedures for manufacturers and suppliers. The Council frames these as simplification measures, not deregulation: safety standards stay as they are.
What does the CLP extension mean?
For chemicals, the legislation pushes the application date of revised CLP requirements to 1 January 2030. Businesses get additional preparation time before the updated hazard classification and labelling rules bind. Fertilising-product rules are also folded into the simplification package.
Why now?
The stated aim is reduced regulatory complexity and lower compliance costs for European cosmetics manufacturers and ingredient suppliers. The Council's rationale centers on competitiveness: the changes could give formulators greater flexibility in formulation development, ingredient substitution and regulatory planning.
For dermatology-adjacent brands and suppliers, the practical read is planning certainty. Longer CMR timelines soften the cost of forced reformulation, and the 2030 CLP date moves hazard-labelling compliance work further out. Nothing in the package weakens the safety dossier a product needs before it reaches EU shelves.
The regulation takes effect 20 days after its Official Journal publication, expected before the end of 2026.
Source: globalcosmeticsnews.com
Tom Whitfield
Show full bio
Senior reporter covering companies, deals and strategy in Clinical dermatology, inflammatory skin disease and biologics at Derm Field.